Metabolism of ellipticine and derivatives and its involvement in the antitumor action of these drugs
- 9 December 1978
- Vol. 60 (9) , 1003-1009
- https://doi.org/10.1016/s0300-9084(78)80587-2
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Hydroxylation de l'ellipticine chez le rat: structure des deux principaux métabolites. Synthèse de l'hydroxy-7 ellipticineTetrahedron Letters, 1978
- Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264-137) in advanced human cancersPublished by Elsevier ,1978
- Ellipticines as potent inhibitors of aryl hydrocarbon hydroxylase: Their binding to microsomal cytochromes p450 and protective effect against benzo(a)pyrene mutagenicityBiochemical Pharmacology, 1978
- Some antitumor derivatives of ellipticine deprived of mutagenic propertiesChemico-Biological Interactions, 1977
- The hydroxylation of the antitumor agent, ellipticine, by liver microsomes from differently pretreated ratsBiochemical Pharmacology, 1977
- Aromatic hydroxylation of ellipticine in rats: Lack of an NIH shiftJournal of Mass Spectrometry, 1976
- Toxicological and pharmacological studies on 9-hydroxy-ellipticine in miceToxicology and Applied Pharmacology, 1975
- A new DNA intercalating drug: Methoxy‐9‐ellipticineFEBS Letters, 1971
- Synthesis of the tumour-inhibitory alkaloids, ellipticine, 9-methoxyellipticine, and related pyrido[4,3-b]carbazolesAustralian Journal of Chemistry, 1967
- Cure of Mice bearing Advanced Plasma Cell Tumours with Aniline Mustard : the Relationship between Glucuronidase Activity and Tumour SensitivityNature, 1966